Targeted-cancer treatments has taken over the industry of cancer research. These are some of the most advanced cancer-fighting medications on the planet and for good reasons. Antibody-drug conjugates just so happens to be some of the top medications, and they are designed to attack cancer cells that are within the body. Once the medications attach themselves to the target, the medications will deliver a cell-killing blow. The name targeted-cancer treatments is the perfect personification of what it truly does. That can’t be said for many of the other cancer fighting medication of today.
Dr. Clay Siegall, CEO and founder of Seattle Genetics, is at the top of the ranks, especially when it comes to this subject. This brilliant-minded individual has made a huge name for himself thanks to his knowledge, his expertise, and his experience. “I’ve always been interested in medicine,” said Siegall. Restoring health to people who have received a dreaded terminal prognosis is the main goal. Siegall has held many prominent positions with some of the industry’s biggest of brands. In the back of his mine, he was still an employee, but he has a number of ideas that could shoot him to the top of the ranks. By owning your own patents, you can control your own products and this is why Siegall switched to playing ball with the big balls. Yes, his previous ideas were making money, but the money was going straight to the institution that he was working for. This is when Siegall decided to control his own destiny and as of today, he is currently the holder of multiple medical patents.
This man is a modern-day success story, and his many accomplishments can’t be disputed. Dr. Clay Siegall is in it to win it and Seattle Genetics is his personal weapon of choice.